Valganciclovir hydrochloride (Valcyte): a new antiviral agent.
Weiskittel
Pat
P
Renal Transplant Department, University Hospital, Cincinnati, OH, USA.
D000284:Administration, Oral; D000998:Antiviral Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001682:Biological Availability; D002986:Clinical Trials as Topic; D017726:Cytomegalovirus Retinitis / Q000188:drug therapy / Q000191:economics; D016527:Drug Costs; D004347:Drug Interactions; D015774:Ganciclovir / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D006435:Renal Dialysis / Q000451:nursing; D000077562:Valganciclovir
D000998:Antiviral Agents; D000077562:Valganciclovir; D015774:Ganciclovir